Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 618.75
-4.15 (-0.67%)
At close: Sep 4, 2026
Lincoln Pharmaceuticals Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 6,942 | 6,710 | 6,232 | 5,805 | 5,103 | 4,721 |
Revenue Growth | 10.20% | 7.67% | 7.35% | 13.76% | 8.09% | 11.30% |
Gross Profit Gross Profit Growth | 3,673 | 3,599 | 3,262 | 2,975 | 2,646 | 2,502 |
Operating Income Operating Income Growth | 864.05 | 831.84 | 890.57 | 895.83 | 805.47 | 876.98 |
Net Income Net Income Growth | 964.53 | 878.94 | 823.46 | 933.05 | 728.99 | 693.55 |
Earnings Per Share EPS Growth | 48.15 | 43.88 | 41.11 | 46.58 | 36.40 | 34.63 |
EPS Growth | 11.69% | 6.74% | -11.74% | 27.98% | 5.11% | 11.41% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 2,360 | 2,180 | 2,172 | 2,040 |
Rest of World Rest of World Growth | 3,872 | 3,625 | 2,931 | 2,681 |
Total Total Growth | 6,232 | 5,805 | 5,103 | 4,721 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,412 | 2,412 | 1,957 | 1,524 | 1,080 | 1,151 |
Total Debt Total Debt Growth | 44.22 | 44.22 | - | 10.67 | 19.97 | 20.44 |
Net Cash (Debt) Net Cash Growth | 2,368 | 2,368 | 1,957 | 1,514 | 1,060 | 1,131 |
Net Cash Growth | 20.71% | 20.98% | 29.28% | 42.76% | -6.22% | 20.31% |
Net Cash Per Share Net Cash Per Share Growth | 118.20 | 118.21 | 97.71 | 75.58 | 52.94 | 56.46 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 1,064 | 930.16 | 632.17 | 392.62 | 761.32 |
Capital Expenditures CapEx Growth | - | -254.28 | -190.29 | -394.76 | -142.59 | -455.25 |
Free Cash Flow Free Cash Flow Growth | - | 809.31 | 739.86 | 237.41 | 250.03 | 306.07 |
Free Cash Flow Growth | - | 9.39% | 211.64% | -5.05% | -18.31% | -49.43% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 52.91% | 53.63% | 52.34% | 51.24% | 51.84% | 52.99% |
Operating Margin | 12.45% | 12.40% | 14.29% | 15.43% | 15.78% | 18.57% |
Pretax Margin | 18.41% | 17.23% | 17.52% | 21.06% | 19.69% | 20.32% |
Profit Margin | 13.89% | 13.10% | 13.21% | 16.07% | 14.29% | 14.69% |
FCF Margin | - | 12.06% | 11.87% | 4.09% | 4.90% | 6.48% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.800 | 1.800 | 1.800 | 1.800 | 1.500 | 1.500 |
Dividend Per Share Growth | 0% | 0% | 0% | 20.00% | 0% | 0% |
Dividend Yield | 0.29% | 0.32% | 0.33% | 0.31% | 0.45% | 0.49% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 12.85 | 12.86 | 13.42 | 12.57 | 9.31 | 8.98 |
Forward PE | - | 7.52 | 7.52 | 7.52 | 7.52 | 7.52 |
P/FCF Ratio | 15.31 | 13.97 | 14.93 | 49.39 | 27.13 | 20.36 |
PS Ratio | 1.79 | 1.69 | 1.77 | 2.02 | 1.33 | 1.32 |